Venetoclax for Acute Myeloid Leukemia in Pediatric Patients: A Texas Medical Center Experience

SIMPLE SUMMARY: Pediatric patients with relapsed or refractory acute myeloid leukemia (AML) have poor survival with current therapy. Venetoclax is a small molecule inhibitor that has shown promise in both adult and pediatric leukemias. Here we describe the joint experience of the Texas Medical Cente...

Descripción completa

Detalles Bibliográficos
Autores principales: Trabal, Adriana, Gibson, Amber, He, Jiasen, McCall, David, Roth, Michael, Nuñez, Cesar, Garcia, Miriam, Buzbee, Meredith, Toepfer, Laurie, Bidikian, Aram, Daver, Naval, Kadia, Tapan, Short, Nicholas J., Issa, Ghayas C., Ravandi, Farhad, DiNardo, Courtney D., Montalban Bravo, Guillermo, Garces, Sofia, Marcogliese, Andrea, Paek, Hana, Dreyer, Zoann, Brackett, Julienne, Redell, Michele, Yi, Joanna, Garcia-Manero, Guillermo, Konopleva, Marina, Stevens, Alexandra, Cuglievan, Branko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093646/
https://www.ncbi.nlm.nih.gov/pubmed/37046645
http://dx.doi.org/10.3390/cancers15071983

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093646/
https://www.ncbi.nlm.nih.gov/pubmed/37046645
http://dx.doi.org/10.3390/cancers15071983

Ejemplares similares